Join
Live feed
·
INSIDERFilingvia Quantisnow
Talaris Therapeutics Inc. logo

Castelein Caley bought $280,584 worth of shares (20,000 units at $14.03), increasing direct ownership by 4% to 516,519 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TALS· Talaris Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TALS (Talaris Therapeutics Inc.) and more on Quantisnow.